- Release Date: 17/10/23 09:13
- Summary: Anatara IBS trial positive secondary endpoint data analysis
- Price Sensitive: Yes
- Download Document 451.5KB
- Forums
- ASX - By Stock
- ANR
- Ann: Anatara IBS trial positive secondary endpoint data analysis
Ann: Anatara IBS trial positive secondary endpoint data analysis
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ANR (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.9¢ |
Change
0.001(2.08%) |
Mkt cap ! $8.059M |
Open | High | Low | Value | Volume |
4.9¢ | 4.9¢ | 4.9¢ | $500 | 10.20K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4529 | 4.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.9¢ | 31094 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4529 | 0.048 |
1 | 20000 | 0.046 |
1 | 25000 | 0.044 |
1 | 15000 | 0.042 |
2 | 168518 | 0.040 |
Price($) | Vol. | No. |
---|---|---|
0.049 | 31094 | 1 |
0.055 | 100000 | 1 |
0.070 | 21725 | 1 |
0.078 | 26000 | 1 |
0.079 | 9000 | 1 |
Last trade - 10.00am 07/05/2024 (20 minute delay) ? |
Featured News
ANR (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online